News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|August 9, 2011

Efficacy and Safety of Highly Purified Menotrophin vs Recombinant FSH in IVF/ICSI Cycles

Author(s)OBGYN.net Staff

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

One in 3 community health centers lack on-site prenatal care, national study finds | Image credit: stock.adobe.com

One in 3 community health centers lack on-site prenatal care, national study finds

ByContemporary OB/GYN Staff

August 3rd 2026

Joy Baker, MD, talks zuranolone's onset for postpartum depression

Joy Baker, MD, talks zuranolone's onset for postpartum depression

ByJoshua Fitch, Senior Editor ,Joy Baker, MD, OBGYN, FACOG, PMH-C, C-EFM, MT(ASCP)

July 30th 2026

New fertility tool to help determine chances of successful IVF launches | stock.adobe.com.

New fertility tool to help determine chances of successful IVF launches

ByJoshua Fitch, Senior Editor

July 29th 2026

Subfecundity, not IVF, linked to elevated neurodevelopmental risk in offspring | Image credit: stock.adobe.com.

Subfecundity, not IVF, linked to elevated neurodevelopmental risk in offspring

ByJoshua Fitch, Senior Editor

July 28th 2026

Late preterm hypoglycemia not tied to neurodevelopment at age 6

Late preterm hypoglycemia not tied to neurodevelopment at age 6

ByJoshua Fitch, Senior Editor

July 27th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Contemporary OB/GYN’s top expert interviews from July 2026

Joy Baker, MD, talks zuranolone's onset for postpartum depression

Jeffrey Jensen, MD, reacts to FDA approval of new contraception patch, Gwyn Lo

Bacterial vaginosis independently associated with increased STI co-infection

Top FDA & regulatory news you missed in July, from Contemporary OB/GYN